ENDOGEN ApS: Financial statements 2020
CVR: 29813337
Source: annual report 2020, Danish Business Authority
27/10/2019 – 26/10/2020
ENDOGEN ApS (CVR 29813337) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -18,293 and a net result of DKK -18,432 compared with DKK -48,651 the year before. Equity in the 2020 report amounted to DKK 78,838. The solvency ratio was 86.3%. The company had 1 employee in the financial year.
- Gross Profit
- DKK -18,293
- Profit/Loss
- DKK -18,432
- Equity
- DKK 78,838
- Total Assets
- DKK 91,338
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | -18 t. | -18 t. | 79 t. | 1 |
| 2019 | - | -48 t. | -49 t. | 97 t. | 1 |
| 2018 | - | -26 t. | -26 t. | 83 t. | 1 |
| 2017 | 0 | -7 t. | -7 t. | 36 t. | - |
| 2016 | 0 | -13 t. | -14 t. | 43 t. | - |
How creditworthy is ENDOGEN ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
ENDOGEN ApS has published its annual report for 2019. Gross profit came to DKK -47,897, and the net result was DKK -48,651.
About ENDOGEN ApS
ENDOGEN ApS is a Danish company of the type Anpartsselskab based in Aarhus C, founded in 2008. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Simon Glerup Pedersen. The company is owned by KOLLISION ApS, Camilla Gustafsen Consulting ApS and Simon Glerup Consulting ApS. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK 113,212 and a net result of DKK -79,499 compared with DKK -22,939 the year before. Equity in the 2025 report amounted to DKK -82,428.